Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
Applicable field (uses covered by this announcement)
Investor relations and corporate presentations for investors
Launch date28 and 29 August 2026 (scheduled)
Relationship between the counterparty and the company
Tsubota Laboratory Incorporated4890
Relationship with the Company
Relationship concerning exhibition and participation in the IR event
CounterpartyNikkei Inc. and Japan Exchange Group, Inc.
Organizers of Nikkei/TSE IR Fair 2026. Other details: Not disclosed
Location (as indicated in this announcement)
Tokyo Big Sight, South Halls 3 and 4 (3-11-1 Ariake, Koto-ku, Tokyo)
Offering price
Admission fee: Free
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Counterparty | Nikkei Inc. and Japan Exchange Group, Inc. |
| Counterparty overview | Organizers of Nikkei/TSE IR Fair 2026. Other details: Not disclosed |
| Relationship with the Company | Relationship concerning exhibition and participation in the IR event |
| Offering price | Admission fee: Free |
| Launch date | 28 and 29 August 2026 (scheduled) |
| Applicable area | Investor relations and corporate presentations for investors |
| Location | Tokyo Big Sight, South Halls 3 and 4 (3-11-1 Ariake, Koto-ku, Tokyo) |
Items this document does not state (11)
Names of Products / Services CoveredContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To clearly explain the progress of the Company's R&D pipeline, research organization, business model and growth strategy to individual investors, and answer their questions directly.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.